- Conditions
- Inactivated Influenza Vaccine
- Interventions
- 2005-2006 trivalent inactivated influenza vaccine
- Biological
- Lead sponsor
- Seattle Children's Hospital
- Other
- Eligibility
- 42 Days to 84 Days
- Enrollment
- 1,375 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005 – 2007
- U.S. locations
- 1
- States / cities
- Seattle, Washington
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1009–1032
of 1,164
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Influenza, Healthy
- Interventions
- Monovalent Influenza Vaccine, Placebo
- Biological · Other
- Lead sponsor
- MedImmune LLC
- Industry
- Eligibility
- 18 Years to 49 Years
- Enrollment
- 301 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016
- U.S. locations
- 3
- States / cities
- South Miami, Florida • Stockbridge, Georgia • Portland, Oregon
- Conditions
- Diabetes
- Interventions
- Diabetes Digital Intervention, Generic Digital Intervention
- Behavioral
- Lead sponsor
- Evidation Health
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 94,321 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- San Mateo, California
- Conditions
- Flu
- Interventions
- Fluad Vaccine, Fluzone HD Vaccine
- Drug
- Lead sponsor
- David H. Canaday
- Other
- Eligibility
- 65 Years and older
- Enrollment
- 478 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2023
- U.S. locations
- 2
- States / cities
- Cleveland, Ohio
- Conditions
- Influenza
- Interventions
- Influenza Virus Quadrivalent Inactivated Vaccine, Sodium Chloride, 0.9%, VRC-FLUNPF099-00-VP (H1ssF_3928)
- Biological · Other
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 49 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2025
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- Influenza, Human
- Interventions
- F2G22B/DL001Z, F2H23D/DL001Z-NH, F2H23B/DL001Z-NH, F2H23H/DL001Z, FDQ23A-NH (Flu D-QIV), GSK5800544A, Flu D-TIV, F2H23A/DL001Z-NH, F2H23G/DL001Z, Fluzone HD Quadrivalent, Fluzone HD
- Biological · Combination Product
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 845 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2025
- U.S. locations
- 18
- States / cities
- Hialeah, Florida • Miami, Florida • Chicago, Illinois + 14 more
- Conditions
- Vaccine Reaction
- Interventions
- MicronJet, Fluzone® Quadrivalent, Fluzone® High Dose Quadrivalent
- Device · Biological
- Lead sponsor
- Yale University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 139 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2029
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut
- Conditions
- Influenza
- Interventions
- Not listed
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- Up to 11 Months
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 15
- States / cities
- Birmingham, Alabama • Pulaski, Arkansas • Orange, California + 12 more
- Conditions
- Pregnancy, Influenza
- Interventions
- Quadrivalent Intradermal Influenza Vaccine (QIV)
- Biological
- Lead sponsor
- Sanofi Pasteur, a Sanofi Company
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 87 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2019
- U.S. locations
- 5
- States / cities
- San Diego, California • Miami, Florida • Albany, New York + 2 more
- Conditions
- Influenza, Healthy
- Interventions
- FluMist® Quadrivalent, Fluzone® Quadrivalent vaccine
- Biological
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 12 Years to 49 Years
- Enrollment
- 109 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2018
- U.S. locations
- 1
- States / cities
- Stanford, California
- Conditions
- Influenza
- Interventions
- Trivalent DNA Vaccine (PIA0601) with or without DEI-LT (pPJV2012)
- Biological
- Lead sponsor
- PowderMed
- Industry
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 189 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2007
- U.S. locations
- 2
- States / cities
- Lenexa, Kansas • Springfield, Missouri
- Conditions
- COVID-19, Vaccine Adverse Reaction, Vaccine Reaction, Vaccine or Biological Substance, Unspecified Causing Adverse Effects in Therapeutic Use, Corona Virus Infection, Blood Clot, Thrombocytopenia, Neuritis, Vasculitis, Influenza, Guillain-Barré, GWAS, Genetic Sequencing
- Interventions
- vaccinated
- Biological
- Lead sponsor
- Neuroganics LLC
- Industry
- Eligibility
- 5 Years to 99 Years
- Enrollment
- 100,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 1
- States / cities
- Northglenn, Colorado
- Conditions
- Influenza
- Interventions
- Baloxavir Marboxil, Placebo
- Drug · Other
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 363 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 14
- States / cities
- Torrance, California • Denver, Colorado • Decatur, Georgia + 11 more
- Conditions
- Influenza A, Influenza B
- Interventions
- Intravenous hyperimmune immunoglobulin (IVIG), Placebo for IVIG
- Biological
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years and older
- Enrollment
- 329 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2018
- U.S. locations
- 17
- States / cities
- San Diego, California • Denver, Colorado • Chicago, Illinois + 14 more
- Conditions
- Influenza
- Interventions
- live attenuated and inactivated influenza vaccines
- Biological
- Lead sponsor
- Baylor College of Medicine
- Other
- Eligibility
- 4 Years to 18 Years
- Enrollment
- 29,255 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 1998 – 2010
- U.S. locations
- 2
- States / cities
- Temple, Texas • Waco, Texas
- Conditions
- Influenza
- Interventions
- Standard IIV4, Recombinant, Cell-culture
- Biological
- Lead sponsor
- Marshfield Clinic Research Foundation
- Other
- Eligibility
- 18 Years to 64 Years
- Enrollment
- 366 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2024
- U.S. locations
- 1
- States / cities
- Marshfield, Wisconsin
- Conditions
- Avian Influenza, Influenza Immunisation
- Interventions
- AS03, Inactivated influenza H7N9 vaccine, Phosphate Buffered Saline (PBS) diluent
- Drug · Biological · Other
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 19 Years to 99 Years
- Enrollment
- 720 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2019
- U.S. locations
- 5
- States / cities
- Decatur, Georgia • Iowa City, Iowa • Baltimore, Maryland + 2 more
- Conditions
- Influenza, Human
- Interventions
- NanoFlu, Fluzone Quadrivalent
- Biological
- Lead sponsor
- Novavax
- Industry
- Eligibility
- 65 Years and older
- Enrollment
- 2,654 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2020
- U.S. locations
- 19
- States / cities
- Hollywood, Florida • Savannah, Georgia • Stockbridge, Georgia + 16 more
- Conditions
- Influenza, Human
- Interventions
- Poly I:Poly C12U 50 ug, Poly I:Poly C12U 200 ug, Poly I:Poly C12U 500 ug, Poly I:Poly C12U 1250 ug, Placebo, FluMist
- Drug
- Lead sponsor
- AIM ImmunoTech Inc.
- Industry
- Eligibility
- 19 Years to 49 Years
- Enrollment
- 55 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2015
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Influenza
- Interventions
- Not listed
- Lead sponsor
- Quidel Corporation
- Industry
- Eligibility
- Not listed
- Enrollment
- 2,500 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011
- U.S. locations
- 16
- States / cities
- Carlsbad, California • Panorama City, California • San Diego, California + 13 more
- Conditions
- Influenza
- Interventions
- DAS181-F02 formulation, DAS181-F04 formulation, Placebo
- Drug
- Lead sponsor
- Ansun Biopharma, Inc.
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 423 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 1
- States / cities
- San Diego, California
- Conditions
- Inflammatory Bowel Disease (IBD)
- Interventions
- Standard dose Influenza vaccine (SDIV), High dose influenza vaccine (HDIV)
- Biological
- Lead sponsor
- University of Wisconsin, Madison
- Other
- Eligibility
- 18 Years to 64 Years
- Enrollment
- 81 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016 – 2018
- U.S. locations
- 1
- States / cities
- Madison, Wisconsin
- Conditions
- Influenza, Human, Respiratory Syncytial Virus Infections
- Interventions
- Swab
- Diagnostic Test
- Lead sponsor
- LumiraDx UK Limited
- Industry
- Eligibility
- Not listed
- Enrollment
- 525 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020
- U.S. locations
- 20
- States / cities
- Birmingham, Alabama • Encinitas, California • Madera, California + 17 more
- Conditions
- Influenza Vaccines, Aged
- Interventions
- MAS-1 adjuvant and influenza HA antigen, standard dose, inactivated trivalent influenza vaccine (TIV)
- Biological
- Lead sponsor
- US Department of Veterans Affairs
- Federal
- Eligibility
- 65 Years and older
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2014
- U.S. locations
- 4
- States / cities
- Palo Alto, California • Iowa City, Iowa • Minneapolis, Minnesota + 1 more